Search results
1 paź 2024 · Frequency not reported: Weight gain ; Weight gain has been reported with insulin therapy and has been attributed to the anabolic effects of insulin and the decrease in glucosuria. Local. Common (1% to 10%): Injection site reactions (including rash, redness, inflammation, pain, itching, and bruising)
23 cze 2022 · Sudden weight gain may be a sign of fluid buildup and heart failure. Tell your doctor if you take thiazolidinediones or have new or worsening heart failure while taking this drug.
Signs and symptoms that may indicate low blood sugar include: low potassium in your blood, injection site reactions, itching, rash, serious whole body allergic reactions, skin thickening or pits at the injection site, weight gain, and swelling of your hands and feet, and if taken with thiazolidinediones (TZDs), possible heart failure.
22 sty 2024 · Frequency not reported: Weight gain ; Hypoglycemia is the most frequently reported adverse reaction with insulin therapy. It occurs if the dose of the insulin is too high in relation to the insulin requirement. In clinical trials, the frequency of hypoglycemia varied with patient population, dose regimens, and level of glycemic control.
6 lip 2022 · Similarly to other types of insulin, Novolog can cause weight gain. It’s not known how common this side effect occurred in clinical trials of the drug, or how much weight was gained on...
4 sie 2023 · Common NovoLog side effects include hypoglycemia, injection site reactions, and headache. Swelling, weight gain, and diarrhea are also possible. If any NovoLog side effects start interfering with your daily functioning, aren’t going away, or are getting worse, let your healthcare provider know.
15 mar 2023 · In a clinical trial in patients with type 1 diabetes, NOVOLOG and regular human insulin, both administered subcutaneously at a dose of 0.15 units/kg body weight, reached mean maximum concentrations of 82 and 36 mU/L, respectively.
